natgillin/translations-raw huggingface dataset:
Having regard to Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms and amending Regulation (EU) No 648/2012, and in particular Article 497(3) thereof,
ob upoštevanju Uredbe (EU) št. 575/2013 Evropskega parlamenta in Sveta z dne 26. junija 2013 o bonitetnih zahtevah za kreditne institucije in investicijska podjetja ter o spremembi Uredbe (EU) št. 648/2012 in zlasti člena 497(3) Uredbe,
In order to avoid disruption to international financial markets and to prevent penalising institutions by subjecting them to higher own funds requirements during the processes of recognition of existing third-country central counterparties (CCPs), Article 497(2) of Regulation (EU) No 575/2013 established a transitional period during which third-country CCPs with which institutions established in the Union clear transactions may be considered qualifying CCPs by those institutions.
Da bi se izognili motnjam na mednarodnih finančnih trgih in preprečili kaznovanje institucij s povišanjem kapitalskih zahtev med postopki priznanja obstoječih centralnih nasprotnih strank (CNS) s sedežem v tretji državi, je v členu 497(2) Uredbe (EU) št. 575/2013 določeno prehodno obdobje, v katerem lahko institucije s sedežem v Uniji vse CNS s sedežem v tretji državi, s katerimi opravljajo kliring transakcij, štejejo kot kvalificirane CNS.
Regulation (EU) No 575/2013 amended Regulation (EU) No 648/2012 in respect of certain inputs to the calculation of institutions' own funds requirements for exposures to third-country CCPs.
Uredba (EU) št. 575/2013 je spremenila Uredbo (EU) št. 648/2012 glede nekaterih parametrov za izračun kapitalskih zahtev institucij za izpostavljenosti do CNS s sedežem v tretji državi.
Accordingly, Article 89(5a) of Regulation (EU) No 648/2012 requires certain third-country CCPs to report, for a limited period of time, the total amount of initial margin they have received from their clearing members.
V skladu s tem člen 89(5a) Uredbe (EU) št. 648/2012 od nekaterih CNS s sedežem v tretji državi zahteva, da za omejeno obdobje poročajo celoten znesek začetnega kritja, ki so ga dobile od klirinških članov.
That transitional period mirrors the one laid down in Article 497(2) of Regulation (EU) No 575/2013.
Navedeno prehodno obdobje ustreza obdobju, določenem v členu 497(2) Uredbe (EU) št. 575/2013.
That extension should also apply in respect of the time limits laid down in Article 89(5a) of Regulation (EU) No 648/2012.
Navedeno podaljšanje bi se moralo uporabljati tudi za roke iz člena 89(5a) Uredbe (EU) št. 648/2012.
Those transitional periods have been extended until 15 June 2017 by Commission Implementing Regulations (EU) No 591/2014, (EU) No 1317/2014, (EU) 2015/880, (EU) 2015/2326, (EU) 2016/892 and (EU) 2016/2227.
Navedena prehodna obdobja so se z izvedbenimi uredbami Komisije (EU) št. 591/2014, (EU) št. 1317/2014, (EU) 2015/880, (EU) 2015/2326, (EU) 2016/892 in (EU) 2016/2227 podaljšala do 15. junija 2017.
Of the CCPs established in third countries that have applied for recognition so far, 28 CCPs have already been recognised by the European Securities and Markets Authority.
Evropski organ za vrednostne papirje in trge je že priznal 28 CNS od vseh CNS s sedežem v tretjih državah, ki so doslej zaprosile za priznanje.
Of those, two CCPs from the United States of America have been recognised after the adoption of Implementing Regulation (EU) 2016/2227 on the basis of Commission Implementing Decision (EU) 2016/377.
Od teh sta bili dve CNS iz Združenih držav Amerike priznani po sprejetju Izvedbene uredbe (EU) 2016/2227 na podlagi Izvedbenega sklepa Komisije (EU) 2016/377.
In addition, following the adoption of Commission Implementing Decisions (EU) 2016/2269, (EU) 2016/2275, (EU) 2016/2276, (EU) 2016/2277 and (EU) 2016/2278 five CCPs respectively from India, Japan, Brazil, Dubai International Financial Centre and United Arab Emirates have also been recognised.
Po sprejetju izvedbenih sklepov Komisije (EU) 2016/2269, (EU) 2016/2275, (EU) 2016/2276, (EU) 2016/2277 in (EU) 2016/2278 je bilo priznanih tudi pet CNS iz Indije, Japonske, Brazilije, Mednarodnega finančnega centra Dubaj in Združenih arabskih emiratov.
Finally, additional CCPs from India and from New Zealand may be recognised on the basis of Commission Implementing Decisions (EU) 2016/2269 and (EU) 2016/2274, respectively.
Dodatne CNS iz Indije in Nove Zelandije se lahko priznajo na podlagi izvedbenih sklepov Komisije (EU) 2016/2269 oziroma (EU) 2016/2274.
If the transitional period is not extended, institutions established in the Union (or their subsidiaries established outside the Union) having exposures to the remaining third-country CCPs would be required to increase significantly their own funds for those exposures.
Potreba po preprečevanju motenj na trgih zunaj Unije, ki je bila nazadnje razlog za podaljšanje prehodnega obdobja iz člena 497(2) Uredbe (EU) št. 575/2013, bi zato še naprej obstajala tudi po poteku podaljšanja prehodnega obdobja iz Izvedbene uredbe (EU) 2016/2227.
Even if such increases may only be temporary, they could potentially lead to the withdrawal of those institutions as direct participants in those CCPs or, at least temporary, to the cessation of the provision of clearing services to those institutions' clients and thus cause severe disruption in the markets in which those CCPs operate.
Dodatno podaljšanje prehodnega obdobja bi moralo institucijam s sedežem v Uniji (ali njihovim podružnicam zunaj Unije) omogočiti, da bi se izognile znatnemu povečanju kapitalskih zahtev zaradi nezaključenih postopkov priznavanja za CNS, ki na ustrezen in dostopen način opravljajo določeno vrsto storitev kliringa, ki jih institucije s sedežem v Uniji (ali njihove podružnice zunaj Unije) potrebujejo.
The need to avoid disruption to markets outside of the Union that led previously to the extension of the transitional period laid down in Article 497(2) of Regulation (EU) No 575/2013 would therefore remain after the expiry of the extension of the transitional period set out in Implementing Regulation (EU) 2016/2227.
Zato je primerno dodatno šestmesečno podaljšanje prehodnih obdobij.
HAS ADOPTED THIS REGULATION:
Petnajstmesečna obdobja iz člena 497(2) Uredbe (EU) št. 575/2013 oziroma drugega pododstavka člena 89(5a) Uredbe (EU) št. 648/2012, ki so bila nazadnje podaljšana v skladu s členom 1 Izvedbene uredbe (EU) 2016/2227, se podaljšajo za dodatnih šest mesecev do 15. decembra 2017.
The 15-month periods referred to in Article 497(2) of Regulation (EU) No 575/2013 and in the second subparagraph of Article 89(5a) of Regulation (EU) No 648/2012, respectively, as last extended in accordance with Article 1 of Implementing Regulation (EU) 2016/2227, are extended by an additional 6 months until 15 December 2017.
Ta uredba začne veljati tretji dan po objavi v Uradnem listu Evropske unije.
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.
V Bruslju, 6. junija 2017
Done at Brussels, 6 June 2017.
Predsednik
Commission Implementing Regulation (EU) No 591/2014 of 3 June 2014 on the extension of the transitional periods related to own funds requirements for exposures to central counterparties in Regulation (EU) No 575/2013 and Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 165, 4.6.2014, p. 31).
Izvedbena uredba Komisije (EU) 2015/880 z dne 4. junija 2015 o podaljšanju prehodnih obdobij iz uredb (EU) št. 575/2013 in (EU) št. 648/2012 Evropskega parlamenta in Sveta v zvezi s kapitalskimi zahtevami za izpostavljenosti do centralnih nasprotnih strank (UL L 143, 9.6.2015, str. 7).
Commission Implementing Regulation (EU) 2015/2326 of 11 December 2015 on the extension of the transitional periods related to own funds requirements for exposures to central counterparties set out in Regulation (EU) No 575/2013 and Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 328, 12.12.2015, p. 108).
Izvedbena uredba Komisije (EU) 2016/2227 z dne 9. decembra 2016 o podaljšanju prehodnih obdobij iz Uredbe (EU) št. 575/2013 in Uredbe (EU) št. 648/2012 Evropskega parlamenta in Sveta v zvezi s kapitalskimi zahtevami za izpostavljenosti do centralnih nasprotnih strank (UL L 336, 10.12.2016, str. 36).
Commission Implementing Regulation (EU) 2016/892 of 7 June 2016 on the extension of the transitional periods related to own funds requirements for exposures to central counterparties set out in Regulation (EU) No 575/2013 and Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 151, 8.6.2016, p. 4).
Izvedbeni sklep Komisije (EU) 2016/377 z dne 15. marca 2016 o enakovrednosti regulativnega okvira Združenih držav Amerike za centralne nasprotne stranke, ki imajo dovoljenje Komisije za trgovanje z blagovnimi terminskimi pogodbami in so pod njenim nadzorom, zahtevam Uredbe (EU) št. 648/2012 Evropskega parlamenta in Sveta (UL L 70, 16.3.2016, str. 32).
Commission Implementing Regulation (EU) 2016/2227 of 9 December 2016 on the extension of the transitional periods related to own funds requirements for exposures to central counterparties set out in Regulation (EU) No 575/2013 and Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 336, 10.12.2016, p. 36).
Izvedbeni sklep Komisije (EU) 2016/2269 z dne 15. decembra 2016 o enakovrednosti regulativnega okvira Indije za centralne nasprotne stranke v skladu z Uredbo (EU) št. 648/2012 Evropskega parlamenta in Sveta (UL L 342, 16.12.2016, str. 38).
Commission Implementing Decision (EU) 2016/377 of 15 March 2016 on the equivalence of the regulatory framework of the United States of America for central counterparties that are authorised and supervised by the Commodity Futures Trading Commission to the requirements of Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 70, 16.3.2016, p. 32).
Izvedbeni sklep Komisije (EU) 2016/2275 z dne 15. decembra 2016 o enakovrednosti regulativnega okvira Japonske za centralne nasprotne stranke v skladu z Uredbo (EU) št. 648/2012 Evropskega parlamenta in Sveta (UL L 342, 16.12.2016, str. 57).
Commission Implementing Decision (EU) 2016/2269 of 15 December 2016 on the equivalence of the regulatory framework for central counterparties in India in accordance with Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 342, 16.12.2016, p. 38).
Izvedbeni sklep Komisije (EU) 2016/2276 z dne 15. decembra 2016 o enakovrednosti regulativnega okvira Brazilije za centralne nasprotne stranke v skladu z Uredbo (EU) št. 648/2012 Evropskega parlamenta in Sveta (UL L 342, 16.12.2016, str. 61).
Commission Implementing Decision (EU) 2016/2275 of 15 December 2016 on the equivalence of the regulatory framework for central counterparties in Japan in accordance with Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 342, 16.12.2016, p. 57).
Izvedbeni sklep Komisije (EU) 2016/2277 z dne 15. decembra 2016 o enakovrednosti regulativnega okvira Mednarodnega finančnega centra Dubaj za centralne nasprotne stranke v skladu z Uredbo (EU) št. 648/2012 Evropskega parlamenta in Sveta (UL L 342, 16.12.2016, str. 65).
Commission Implementing Decision (EU) 2016/2276 of 15 December 2016 on the equivalence of the regulatory framework for central counterparties in Brazil in accordance with Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 342, 16.12.2016, p. 61).
Izvedbeni sklep Komisije (EU) 2016/2278 z dne 15. decembra 2016 o enakovrednosti regulativnega okvira Združenih arabskih emiratov za centralne nasprotne stranke v skladu z Uredbo (EU) št. 648/2012 Evropskega parlamenta in Sveta (UL L 342, 16.12.2016, str. 68).
Commission Implementing Decision (EU) 2016/2277 of 15 December 2016 on the equivalence of the regulatory framework for central counterparties in the Dubai International Financial Centre in accordance with Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 342, 16.12.2016, p. 65).
Izvedbeni sklep Komisije (EU) 2016/2274 z dne 15. decembra 2016 o enakovrednosti regulativnega okvira Nove Zelandije za centralne nasprotne stranke v skladu z Uredbo (EU) št. 648/2012 Evropskega parlamenta in Sveta (UL L 342, 16.12.2016, str. 54).
Commission Implementing Decision (EU) 2016/2278 of 15 December 2016 on the equivalence of the regulatory framework for central counterparties in the United Arab Emirates in accordance with Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 342, 16.12.2016, p. 68).
Kljub temu razvoju preostale CNS s sedežem v tretji državi še vedno čakajo na priznanje, pri čemer postopek priznavanja ne bo zaključen do 15. junija 2017.
Commission Implementing Decision (EU) 2016/2274 of 15 December 2016 on the equivalence of the regulatory framework for central counterparties in New Zealand in accordance with Regulation (EU) No 648/2012 of the European Parliament and of the Council (OJ L 342, 16.12.2016, p. 54).
Če prehodno obdobje ne bi bilo podaljšano, bi morale institucije s sedežem v Uniji (ali njihove podružnice zunaj Unije), ki imajo izpostavljenosti do preostalih CNS s sedežem v tretji državi, znatno povečati svoj kapital za navedene izpostavljenosti.
on the classification of horizontal settlement and short-term water absorption performance for in situ formed loose fill cellulose (LFCI) thermal insulation products under EN 15101-1 pursuant to Regulation (EU) No 305/2011 of the European Parliament and of the Council
o razvrstitvi lastnosti vodoravnega posedanja in kratkoročne absorpcije vode za toplotnoizolacijske razsute celulozne proizvode na podlagi EN 15101-1 v skladu z Uredbo (EU) št. 305/2011 Evropskega parlamenta in Sveta
Having regard to Regulation (EU) No 305/2011 of the European Parliament and of the Council of 9 March 2011 laying down harmonised conditions for the marketing of construction products and repealing Council Directive 89/106/EEC [1], and in particular Article 27(1) thereof,
ob upoštevanju Uredbe (EU) št. 305/2011 Evropskega parlamenta in Sveta z dne 9. marca 2011 o določitvi usklajenih pogojev za trženje gradbenih proizvodov in razveljavitvi Direktive Sveta 89/106/EGS [1] ter zlasti člena 27(1) Uredbe,
Where the Commission has not established classes of performance in relation to the essential characteristics of construction products, according to Article 27(2) of Regulation (EU) No 305/2011 they may be established by the European standardisation bodies, but only on the basis of a revised mandate.
Kadar Komisija ni določila razredov lastnosti v zvezi z bistvenimi značilnostmi gradbenih proizvodov v skladu s členom 27(2) Uredbe (EU) št. 305/2011, jih lahko določijo evropski organi za standardizacijo, vendar samo na podlagi spremenjenega mandata.
The European product standard EN 15101-1 on in situ formed loose fill cellulose (LFCI) thermal insulation products contains classifications of performance concerning two of their essential characteristics, settlement for horizontal applications, lofts and floors, as well as short-term water absorption.
Evropski standard EN 15101-1 o toplotnoizolacijskih razsutih celuloznih proizvodih (LFCI) vsebuje razvrstitve lastnosti glede dveh njegovih bistvenih značilnosti, in sicer posedanja za vodoravne uporabe, podstrešja in tla ter kratkoročne absorpcije vode.
These classifications represent a step forward for the consolidation of the internal market for the products in question.
Te razvrstitve pomenijo korak naprej pri konsolidaciji notranjega trga za zadevne proizvode.
For those new classifications, a revised mandate has not been issued.
Za navedene nove razvrstitve ni bil izdan spremenjen mandat.
New classification systems to be used for products covered by EN 15101-1 should therefore be established,
Zato bi bilo treba določiti nove sisteme razvrščanja za proizvode, ki jih zajema standard EN 15101-1 –
The performance of in situ formed loose fill cellulose (LFCI) thermal insulation products, in relation to their essential characteristics, settlement for horizontal applications, lofts and floors, as well as short-term water absorption, shall be classified in accordance with the classification systems set out in the Annex.
Lastnost toplotnoizolacijskih razsutih celuloznih proizvodov v zvezi z njihovima bistvenima značilnostma, ki sta posedanje za vodoravne uporabe, podstrešja in tla ter kratkoročna absorpcija vode, se razvrsti v skladu s sistemi razvrščanja iz Priloge.
Classes for settlement for horizontal applications, lofts and floors
Razredi glede posedanja za vodoravne uporabe, podstrešja in tla
No measureable settlement (≤ 1 %)
Ni merljivega posedanja (≤ 1 %)
Classes of short-term water absorption
Razredi kratkoročne absorpcije vode
> 2,0 kg/m2
≤ 2,0 kg/m2
Commission Implementing Regulation (EU) 2017/960
Izvedbena uredba Komisije (EU) 2017/960
Pursuant to those general rules, the goods described in column (1) of the table set out in the Annex should be classified under the CN code indicated in column (2), by virtue of the reasons set out in column (3) of that table.
Po teh splošnih pravilih bi bilo blago iz stolpca 1 razpredelnice iz Priloge treba uvrstiti pod oznako KN v stolpcu 2 na podlagi utemeljitve v stolpcu 3 navedene razpredelnice.
A product in the form of a brownish, turbid extract of vanilla beans (which contains water and 35 % vol. alcohol as solvents), to which 5 % by weight of sugar has been added.
Izdelek v obliki rjavkastega, motnega ekstrakta vanilijevih strokov (ki vsebuje vodo in 35 vol. % alkohola kot topila), ki mu je bilo dodano 5 mas. % sladkorja.
The product has an intense vanilla flavour and a distinctive taste of alcohol and sugar.
Izdelek ima intenzivno aromo vanilije ter značilen okus po alkoholu in sladkorju.
It is put up for retail sale in 100 ml bottles and is used to improve the taste of dishes.
Pakiran je v obliki za prodajo na drobno v stekleničkah po 100 ml in se uporablja za izboljšanje okusa jedi.
Classification is determined by general rules 1 and 6 for the interpretation of the Combined Nomenclature and the wording of CN codes 2103, 210390 and 21039090.
Uvrstitev opredeljujejo splošni pravili 1 in 6 za razlago kombinirane nomenklature ter besedilo oznak KN 2103, 210390 in 21039090.
The product cannot be considered as a vegetable extract of heading 1302 as due to the addition of sugar it has the character of a food preparation (see also the Harmonized System Explanatory Notes (HSEN) to heading 1302, point (A), sixth paragraph).
Izdelek se ne more šteti kot rastlinski ekstrakt iz tarifne številke 1302, ker ima zaradi dodanega sladkorja značilnosti prehrambenega izdelka (glej tudi pojasnjevalne opombe harmoniziranega sistema k tarifni številki 1302, točka (A), šesti odstavek).
Preparations used to flavour certain dishes and made from various ingredients are to be classified under heading 2103 (see also the HSEN to heading 2103, point (A), first paragraph).
Pripravki, ki se uporabljajo za aromatiziranje nekaterih jedi in sestojijo iz različnih sestavin, se uvrščajo pod tarifno številko 2103 (glej tudi pojasnjevalne opombe harmoniziranega sistema k tarifni številki 2103, točka (A), prvi odstavek).
The product is therefore to be classified under CN code 21039090 as a mixed condiment or seasoning.
Izdelek je zato treba uvrstiti pod oznako KN 21039090 kot mešanico začimb ali dišavno mešanico.
Commission Implementing Regulation (EU) 2017/961
Izvedbena uredba Komisije (EU) 2017/961
concerning the authorisation of a preparation of Enterococcus faecium CECT 4515 as a feed additive for weaned piglets, and a new use in water for drinking for weaned piglets and chickens for fattening, and amending Regulation (EC) No 2036/2005 and Regulation (EU) No 887/2011 (holder of authorisation Evonik Nutrition & Care GmbH)
o izdaji dovoljenja za pripravek iz Enterococcus faecium Enterococcus faecium CECT 4515 kot krmni dodatek za odstavljene pujske ter za novo uporabo v vodi za pitje za odstavljene pujske in piščance za pitanje ter o spremembi uredb (ES) št. 2036/2005 in (EU) št. 887/2011 (imetnik dovoljenja Evonik Nutrition & Care GmbH)
The preparation of Enterococcus faecium CECT 4515 was authorised without a time limit in accordance with Directive 70/524/EEC as a feed additive for weaned piglets by Commission Regulation (EC) No 2036/2005 [3].
Pripravek iz Enterococcus faecium CECT 4515 je bil z Uredbo Komisije (ES) št. 2036/2005 [3] odobren brez časovne omejitve za odstavljene pujske v skladu z Direktivo 70/524/EGS.
That preparation was subsequently entered in the Register of Feed Additives as an existing product, in accordance with Article 10(1)(b) of Regulation (EC) No 1831/2003.
Navedeni pripravek je bil v skladu s členom 10(1)(b) Uredbe (ES) št. 1831/2003 naknadno vpisan v register krmnih dodatkov kot obstoječi proizvod.
That preparation has been authorised for chickens for fattening by Commission Implementing Regulation (EU) No 887/2011 [4].
Navedeni pripravek je bil z Izvedbeno uredbo Komisije (EU) št. 887/2011 [4] odobren za piščance za pitanje.
In accordance with Article 10(2) of Regulation (EC) No 1831/2003 in conjunction with Article 7 of that Regulation, applications were submitted for the re-evaluation of the preparation of Enterococcus faecium CECT 4515 as a feed additive in feed for weaned piglets and for a new use in water for drinking for weaned piglets and chickens for fattening.
V skladu s členom 10(2) Uredbe (ES) št. 1831/2003 v povezavi s členom 7 navedene uredbe so bili predloženi zahtevki za ponovno oceno pripravka iz Enterococcus faecium CECT 4515 kot krmnega dodatka za odstavljene pujske in za novo uporabo v vodi za pitje za odstavljen pujske in piščance za pitanje.
The applicant requested the additive to be classified in the additive category ‘zootechnical additives’.
Vložnik je zahteval, da se navedeni dodatek uvrsti v kategorijo dodatkov „zootehnični dodatki“.
The European Food Safety Authority (‘the Authority’) concluded in its opinions of 9 April 2014 [5], 29 April 2015 [6] and 8 September 2015 [7] that, under the proposed conditions of use, the preparation of Enterococcus faecium CECT 4515 does not have an adverse effect on animal health, human health or the environment.
Evropska agencija za varnost hrane (v nadaljnjem besedilu: Agencija) je v mnenjih z dne 9. aprila 2014 [5], 29. aprila 2015 [6] in 8. septembra 2015 [7] navedla, da pripravek iz Enterococcus faecium CECT 4515 pod predlaganimi pogoji uporabe nima škodljivega vpliva na zdravje živali in ljudi ali na okolje.
In its opinion of 29 April 2015, the Authority also concluded that the additive has the potential to improve the zootechnical performance of weaned piglets when used in feed.
Agencija je v mnenju z dne 29. aprila 2015 tudi navedla, da lahko dodatek izboljša proizvodne lastnosti odstavljenih pujskov, kadar se uporablja v krmi.
In its opinion of 8 September 2015, the Authority further concluded that the use of the preparation of Enterococcus faecium CECT 4515 in water for drinking for weaned piglets and chickens for fattening has the same efficacy as when it is used in feed.
V svojem mnenju z dne 8. septembra 2015 je Agencija prav tako navedla, da ima uporaba pripravka iz Enterococcus faecium Enterococcus faecium CECT 4515 v vodi za pitje za odstavljene pujske in piščance za pitanje isti učinek kot uporaba v krmi.
The assessment of the preparation of Enterococcus faecium CECT 4515 shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Ocena pripravka iz Enterococcus faecium CECT 4515 je pokazala, da so pogoji za dovoljenje iz člena 5 Uredbe (ES) št. 1831/2003 izpolnjeni.
Accordingly, the use of that preparation should be authorised as specified in the Annexes to this Regulation.
Zato bi bilo treba dovoliti uporabo navedenega pripravka, kakor je opredeljeno v prilogah k tej uredbi.
As a consequence of the granting of a new authorisation under Regulation (EC) No 1831/2003, Regulation (EC) No 2036/2005 should be amended accordingly.
Zaradi izdaje novega dovoljenja v skladu z Uredbo (ES) št. 1831/2003 bi bilo treba ustrezno spremeniti Uredbo (ES) št. 2036/2005.